This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Most Read Pharmaceutical And Health News - January '13

AUSTIN, Texas, Feb. 5, 2013 /PRNewswire/ -- dailyRx News announced today the most popular health topics viewed and shared during January 2013.  dailyRx News publishes and syndicates consumer-centric health information across affiliated websites, YouTube, various news aggregators, and to patients through a national network of healthcare providers' social media channels.

"dailyRx News reports on medication and health research distributed by the FDA, medical schools, and clinical trials," said Donald W. Hackett, CEO and Publisher of dailyRx News. "dailyRx's reporters and medical editors understand the importance of translating medical terminology into information that everyone can understand.  We focus on publishing content that is timely, accurate, and actionable," Hackett added. 

According to the Pew Research Center's Internet & American Life Project, 35% of American adults have searched the web specifically to learn about a medical condition they or someone they know might have. "With an increasing number of Americans accessing digital information for initial self-diagnosis purposes, there is no room in today's news industry for outdated information, biased research, or reader confusion," Hackett said. 

Health conditions generating notable viewer engagement on dailyRx.com last month included:

January's most-viewed medications included:

Trending health news throughout dailyRx social media included:

About The dailyRx News Network

The dailyRx News Network is an emerging leader in publishing health news for consumers and patients alike. dailyRx publishes, aggregates, and syndicates doctor-reviewed news covering a wide range of health conditions, medications, over-the-counter products, and nutraceutical compounds. dailyRx's original content is written in positive, unbiased, easy-to-understand language and reviewed for accuracy by doctors, pharmacists, and therapists. dailyRx, Inc. is a Patient Conversation Media, company.

SOURCE dailyRx News

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,399.67 +19.26 0.12%
S&P 500 1,904.01 +17.25 0.91%
NASDAQ 4,316.0740 +57.6360 1.35%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs